Back to search
FDAFDA · Food and drugs·Recall number D-0600-2024

Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.

Published July 24, 2024 · Recall initiated: June 27, 2024

Summary

FDA records drug Class II recall D-0600-2024, published July 24, 2024 and initiated June 27, 2024. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: 432250 vials; Lot: Lot #: L200253, L200281, L200301, Exp 07/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: glass

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
TN
Lot
Lot #: L200253, L200281, L200301, Exp 07/31/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01. recalled?

Yes. FDA published recall D-0600-2024 on July 24, 2024. Reported hazard: Presence of particulate matter: glass

What should I do if I have this product?

Voluntary: Firm initiated · Letter